Chesnara plc (LON:CSN - Get Free Report) passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 254.64 ($3.31) and traded as high as GBX 262 ($3.40). Chesnara shares last traded at GBX 252 ($3.27), with a volume of 262,285 shares trading hands.
Chesnara Trading Down 0.4 %
The company has a quick ratio of 38.06, a current ratio of 2.35 and a debt-to-equity ratio of 62.78. The business's fifty day moving average is GBX 258.09 and its 200 day moving average is GBX 254.62. The stock has a market cap of £378.88 million, a PE ratio of 8,366.67 and a beta of 0.44.
Chesnara Cuts Dividend
The company also recently declared a dividend, which will be paid on Friday, November 1st. Stockholders of record on Thursday, September 19th will be paid a dividend of GBX 8.61 ($0.11) per share. This represents a dividend yield of 3.27%. The ex-dividend date of this dividend is Thursday, September 19th. Chesnara's dividend payout ratio (DPR) is 80,000.00%.
Insider Activity at Chesnara
In other news, insider Steve Murray bought 11,410 shares of the firm's stock in a transaction on Tuesday, September 10th. The shares were bought at an average cost of GBX 262 ($3.40) per share, for a total transaction of £29,894.20 ($38,813.55). 5.47% of the stock is currently owned by company insiders.
About Chesnara
(
Get Free Report)
Chesnara plc, together with its subsidiaries, operates in life assurance and pension businesses primarily in the United Kingdom, the Netherlands, and Sweden. It operates through UK, Movestic, Waard Group, and Scildon segments. The company underwrites life risks, such as death, disability, health, and accident; and provides a portfolio of investment contracts for the savings and retirement needs of customers through asset management, as well as general insurance products.
Recommended Stories
Before you consider Chesnara, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Chesnara wasn't on the list.
While Chesnara currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
